BÜHLMANN at Congress

IBDoc News from ECCO 2017

IBDoc® has now been on the market for over 2 years and it is transforming the way IBD patients manage their disease. IBDoc® is used by over a thousand patients in more than 15 countries and we now support 20 languages with Hebrew as the latest addition. BÜHLMANN as the only calprotectin company has been able

Read more

Connect with BUHLMANN at ECCO 2017

BÜHLMANN will be present with a Booth at ECCO. Don’t miss the chance to get an update on our divers calprotectin product portfolio

Read more